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Background: Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of systemic inflammation. Recent studies have associated 
suPAR with presence and severity of coronary artery disease (CAD). However, the prognostic implication of suPAR in patients with left ventricular 
systolic dysfunction (LVSD) is unknown.
methods: 445 subjects with LVSD undergoing coronary angiography (age: 64 ± 12 years, 71% male, 22% black, 37% diabetes, 78% with CAD, EF: 
29+10%, 34% with NYHA class > 3, 21% with acute myocardial infarction (MI)) from the Emory Cardiovascular Biobank were followed for incident 
death and/or MI and re-hospitalization for heart failure (HF) over a mean 1.8 ± 1 years. Plasma suPAR was measured using ELISA. ROC cutoffs were 
used for survival analysis using Cox regression.
results: There were 90 death or MIs and 54 re-hospitalizations for HF. The ROC cutoff for log suPAR was 1.5. Mean suPAR was higher in those 
with events compared to those without (5.3 vs. 3.7 ng/ml, p<0.001). After adjustment for established CV risk factors, CRP, ejection fraction, NYHA 
class, and medications; high suPAR had a hazard ratio of 2.8 (p= 0.001) for death or MI and 2.1 (P=0.01) for HF re-hospitalization. (Figure). Other 
predictors of death/MI were CRP, glucose, use of ACE-inhibitors, and Gensini CAD severity score.
conclusions: Plasma suPAR levels predict composite outcome of death or MI as well as re-hospitalization for HF, independent of other CVD risk 
factors, CRP, and NYHA class.
